NEW DELHI, (IANS) – Drug makers Cipla and Glenmark are recalling their products from the US market due to manufacturing issues. Following the latest Enforcement Report from the US Food and Drug Administration (USFDA), Cipla’s subsidiary in New Jersey is recalling 59,244 packs of Ipratropium […] Read this story
